CELEX: 62019CB0239
Language: en
Date: 2019-09-05 00:00:00
Title: Case C-239/19: Order of the Court (Ninth Chamber) of 5 September 2019 (request for a preliminary ruling from the High Court of Justice (Chancery Division) – United Kingdom) — Eli Lilly and Company v Genentech Inc. (Reference for a preliminary ruling – Article 53(2) of the Rules of Procedure of the Court of Justice – Supplementary protection certificate for medicinal products – Regulation (EC) No 469/2009 – Article 3(b) – Conditions for obtaining – Marketing authorisation – Authorisation issued to a third party – Manifest inadmissibility)

11.11.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 383/35
            
         
      Order of the Court (Ninth Chamber) of 5 September 2019 (request for a preliminary ruling from the High Court of Justice (Chancery Division) – United Kingdom) — Eli Lilly and Company v Genentech Inc.
      (Case C-239/19) (1)
      
      (Reference for a preliminary ruling - Article 53(2) of the Rules of Procedure of the Court of Justice - Supplementary protection certificate for medicinal products - Regulation (EC) No 469/2009 - Article 3(b) - Conditions for obtaining - Marketing authorisation - Authorisation issued to a third party - Manifest inadmissibility)
      (2019/C 383/39)
      Language of the case: English
      
         Referring court
      
      High Court of Justice (Chancery Division)
      
         Parties to the main proceedings
      
      
         Applicant: Eli Lilly and Company
      
         Defendant: Genentech Inc.
      
         Operative part of the order
      
      The request for a preliminary ruling from the High Court of Justice (England & Wales), Chancery Division (Patents Court) (United Kingdom), made by decision of 4 March 2019, is manifestly inadmissible.
      
         (1)  OJ C 172, 20.5.2019